Best Hospitals for Coronary Artery Angiography (CAG) in UAE

For diagnostic-only Coronary Artery Angiography (CAG), the all-inclusive cost in India ranges from approximately USD 500 to USD 1,500 at JCI- and NABH-accredited tertiary hospitals, making it among the most cost-competitive destinations globally for this procedure. In the UAE (Dubai or Abu Dhabi), at JCI-accredited and DHA/DoH-licensed hospitals, the equivalent procedure costs between approximately USD 1,500 and USD 3,500 — reflecting higher operational overheads and consumable import costs, while maintaining identical international quality and accreditation standards. Both cost ranges cover the procedural fee, catheterization laboratory charges, diagnostic catheters, iodinated contrast agent, standard medications (vasodilators, anticoagulants), fluoroscopy and imaging, one-day hospital stay or overnight observation, and the cardiologist's professional fee. Costs increase substantially if the procedure is extended to include adjunctive technologies (FFR/iFR pressure wire assessment: +USD 300–800; IVUS or OCT: +USD 500–1,500) or if ad-hoc percutaneous coronary intervention (PCI) with drug-eluting stent (DES) placement is performed at the same session (additional USD 1,500–6,000 in India; USD 4,000–12,000 in UAE, depending on the number of stents, stent platform, and bifurcation technique complexity). GAF Healthcare provides fully transparent, itemized cost estimates prior to travel, with written confirmation from the partner hospital, and no hidden administrative charges. Patients typically save 70–85% compared to equivalent-quality procedures performed in the United States, United Kingdom, or Western Europe.

Most patients undergoing elective diagnostic-only CAG via the transradial (wrist) approach are medically fit to travel within 3–5 days of their procedure for short-to-medium-haul international flights (under 6 hours), and within 5–7 days for long-haul intercontinental flights. This timeline reflects the time required for: complete transradial access site hemostasis and early hematoma resolution (radial hemostasis band is removed within 2–4 hours post-procedure); confirmation of stable renal function with no contrast-induced nephropathy (creatinine re-check at 24–48 hours in moderate-risk patients); cardiovascular stability with no post-procedural arrhythmia or hemodynamic compromise requiring monitoring; and the treating cardiologist's formal fitness-to-fly assessment with documentation. If the procedure was extended to include ad-hoc PCI with drug-eluting stent implantation, the recommended pre-flight observation period is typically extended to 5–7 days minimum (short-haul) or 7–10 days (long-haul), to ensure stent stability, confirm dual antiplatelet therapy (DAPT) tolerance, and rule out any subacute complications. Patients with transfemoral access (groin puncture) are advised a minimum of 5 days before air travel due to the larger arteriotomy and longer ambulation recovery requirement. GAF Healthcare's partner cardiologist issues a formal fitness-to-fly medical certificate and procedure summary letter — required by most airlines for recently catheterized patients — prior to the patient's departure. GAF Healthcare's Patient Relationship Manager coordinates the return flight booking in alignment with the treating physician's discharge timeline.

Coronary Artery Angiography achieves a diagnostic technical success rate of ≥ 95–98% in experienced hands at high-volume interventional cardiology centers, which defines the standard maintained at all GAF Healthcare partner hospitals. 'Technical success' is defined as complete visualization of all major coronary vessels and their significant branches with diagnostic-quality imaging, enabling definitive clinical decision-making regarding medical management, PCI, or CABG. The major complication rate (including death, MI, stroke, or emergency surgery) for elective diagnostic CAG is less than 0.5% at accredited high-volume centers — a benchmark consistently met by GAF Healthcare's partner institutions, which collectively perform thousands of CAG procedures annually. The transradial approach, which is the default access route at all GAF Healthcare partner centers, has been demonstrated in large randomized trials (RIVAL, MATRIX) to reduce major access-site bleeding by 60–70% and major adverse cardiac and cerebrovascular events (MACCE) compared to transfemoral access. GAF Healthcare's partner interventional cardiologists hold advanced fellowships from globally recognized institutions, board certifications from national and international cardiology societies (ACC, ESC, CSI, SCAI), and many have subspecialty expertise in complex CAD including CTO-PCI, left main PCI, and high-risk hemodynamic support-assisted PCI. In India, partner hospitals hold NABH and JCI dual accreditation; in the UAE, they hold JCI accreditation alongside DHA (Dubai) or DoH (Abu Dhabi) licensure — ensuring that procedural quality, infection control, radiation safety, and patient rights standards meet the highest international benchmarks.